There is currently no schedule data. The Schedule Release will be available on April.

In the SURPASS-ET trial, the company weighed its treatment, dubbed P1101 in the study, against platelet-reducing anagrelide as a second-line therapy for patients with essential thrombocythemia (ET).

GlobalAir.com receives its data from NOAA, NWS, FAA and NACO, and Weather Underground. We strive to maintain current and accurate data. However, GlobalAir.com cannot guarantee the data received from ...

Bird feathers have been found in the engine of a South Korean passenger jet that crashed, killing 179 people. Jeju Air 7C2216, a Boeing 737-800 jet, was flying from the Thai capital of Bangkok to ...